Spontaneous gangrenous myositis induced by Streptococcus pyogenes: Case report and review of the literature
Yoder EL, Mendez J, Khatib R. Spontaneous gangrenous myositis induced by Streptococcus pyogenes: case report and review of the literature. Rev Infect Dis 1987; 9:382-385
Improved results from a standardized approach in treating patients with necrotizing fasciitis
Sudarsky LA, Laschinger JC, Coppa GF, et al. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg 1987; 206:661-665
Clinical experience with 20 cases of group A streptococcal necrotizing fasciitis and myonecrosis: 1995-1997
Haywood CT, McGeer A, Low DE. Clinical experience with 20 cases of group A streptococcal necrotizing fasciitis and myonecrosis: 1995-1997. Plastic Reconstr Surg 1999; 103: 1567-1573
The Eagle effect revisited: Efficacy of clindamycin, erythromycin and penicillin in the treatment of streptococcal myositis
Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988; 158:23-28
Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements
Riseman JA, Zamboni WA, Curtis A, et al. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery 1990; 108: 847-850
Clinical usefulness of intravenous human immunoglobulins in invasive group A streptococcal infections: Case report and review
Lamothe F, D'Amico P, Ghosn P, et al. Clinical usefulness of intravenous human immunoglobulins in invasive group A streptococcal infections: case report and review. Clin Infect Dis 1995; 21:1469-1470
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome: A comparative observational study
Kaul R, McGeer A, Norrby-Teglund A, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 1999; 28:800-807